Selected Bloodwork and NMR Advanced Lipid Test to Assess CVD Risk and Establish Natural Lipid Lowering Cardioprotective Therapy: A Case Report of a 77-yo female
Published on
October 1, 2021
Abstract
This is a case study of minimally elevated LDL hyperlipidemia with no other biomarkers of underlying driving risk of cardiovascular disease. This clinical picture is one of the best outcomes when addressing LDL hyperlipidemia. Successful analysis of the CBC, CMP, Add-on supportive biomarkers B9, B12, iron, ferritin, homocysteine, CRP, Vitamin D, Hb1Ac, and NMR advanced Lipoprofile ruled out insulin resistance, diabetes, and an underlying CVD risk and allowed for an individualized dietary, lifestyle, and supplement treatment strategy; regimen included.